Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
Accurate rapid diagnostic tests for SARS-CoV-2 infection could contribute to clinical and public health strategies to manage the pandemic. Point-of-care antigen and molecular tests to detect current infection could increase access to testing and early confirmation of cases. We present sensitivity and specificity with 95% confidence intervals (CIs) for each test and pooled data using the bivariate model for antigen and Molecular-based tests. We tabulated results by test manufacturer and complianc
